Matt Biegler
Analyst
Analyst — Opco
Earnings-call appearances
-
CytomX Therapeutics, Inc. Q1 FY2026 Earnings Call2026-05-07
CytomX Therapeutics, Inc. (CTMX)
-
Fulcrum Therapeutics, Inc. Q1 FY2026 Earnings Call2026-04-27
Fulcrum Therapeutics, Inc. (FULC)
-
CytomX Therapeutics, Inc. Q4 FY2025 Earnings Call2026-03-16
CytomX Therapeutics, Inc. (CTMX)
-
CytomX Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-06
CytomX Therapeutics, Inc. (CTMX)
-
Gilead Sciences, Inc. Q1 FY2025 Earnings Call2025-04-24
Gilead Sciences, Inc. (GILD)
-
Gilead Sciences, Inc. Q3 FY2024 Earnings Call2024-11-06
Gilead Sciences, Inc. (GILD)
-
Fate Therapeutics Inc Q2 FY2022 Earnings Call2022-08-03
Fate Therapeutics Inc (FATE)
-
Fate Therapeutics Inc Q4 FY2021 Earnings Call2022-02-28
Fate Therapeutics Inc (FATE)
-
Fate Therapeutics Inc Q3 FY2021 Earnings Call2021-11-04
Fate Therapeutics Inc (FATE)
-
Fate Therapeutics Inc Q2 FY2021 Earnings Call2021-08-04
Fate Therapeutics Inc (FATE)
-
Fate Therapeutics Inc Q4 FY2020 Earnings Call2021-02-24
Fate Therapeutics Inc (FATE)
-
Fate Therapeutics Inc Q3 FY2020 Earnings Call2020-11-05
Fate Therapeutics Inc (FATE)
-
Fate Therapeutics Inc Q2 FY2020 Earnings Call2020-08-05
Fate Therapeutics Inc (FATE)
-
Marker Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-11
Marker Therapeutics, Inc. (MRKR)